Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

1.

Clinical/pathologic features and patient outcome in early onset endometrial carcinoma: a population based analysis and an institutional perspective from the Detroit metropolitan area, Michigan.

Semaan A, Ali-Fehmi R, Munkarah AR, Bandyopadhyay S, Morris RT, Rizk S, Mert I, Ruterbusch JJ, Cote ML.

Gynecol Oncol. 2012 Feb;124(2):265-9. doi: 10.1016/j.ygyno.2011.09.027. Epub 2011 Nov 1.

PMID:
22044605
[PubMed - indexed for MEDLINE]
2.

Defining prognostic variables in recurrent endometrioid endometrial cancer: a 15-year single-institution review.

Esselen KM, Boruta DM, del Carmen M, Schorge JO, Goodman A, Growdon WB.

Int J Gynecol Cancer. 2011 Aug;21(6):1078-83. doi: 10.1097/IGC.0b013e31821872f4.

PMID:
21633304
[PubMed - indexed for MEDLINE]
3.

The effect of age on clinical/pathologic features, surgical morbidity, and outcome in patients with endometrial cancer.

Lachance JA, Everett EN, Greer B, Mandel L, Swisher E, Tamimi H, Goff B.

Gynecol Oncol. 2006 Jun;101(3):470-5. Epub 2006 Jan 18.

PMID:
16413048
[PubMed - indexed for MEDLINE]
4.

The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.

Cirisano FD Jr, Robboy SJ, Dodge RK, Bentley RC, Krigman HR, Synan IS, Soper JT, Clarke-Pearson DL.

Gynecol Oncol. 2000 Apr;77(1):55-65.

PMID:
10739691
[PubMed - indexed for MEDLINE]
5.

[Endometrioid endometrial cancer--the prognostic value of selected clinical and pathological parameters].

Gottwald L, Chałubińska J, Moszyńska-Zielińska M, Piekarski J, Tyliński W, Szwalski J, Kubiak R, Pasz-Walczak G, Hendzel K, Ciałkowska-Rysz A.

Ginekol Pol. 2011 Oct;82(10):743-8. Polish.

PMID:
22379937
[PubMed - indexed for MEDLINE]
6.

Endometrial cancer in the oldest old: Tumor characteristics, patterns of care, and outcome.

Wright JD, Lewin SN, Barrena Medel NI, Sun X, Burke WM, Deutsch I, Herzog TJ.

Gynecol Oncol. 2011 Jul;122(1):69-74. doi: 10.1016/j.ygyno.2011.02.040. Epub 2011 Mar 22.

PMID:
21429570
[PubMed - indexed for MEDLINE]
7.

Intravaginal brachytherapy alone for intermediate-risk endometrial cancer.

Alektiar KM, Venkatraman E, Chi DS, Barakat RR.

Int J Radiat Oncol Biol Phys. 2005 May 1;62(1):111-7.

PMID:
15850910
[PubMed - indexed for MEDLINE]
8.

The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.

Jolly S, Vargas CE, Kumar T, Weiner SA, Brabbins DS, Chen PY, Floyd W, Martinez AA.

Gynecol Oncol. 2006 Oct;103(1):87-93. Epub 2006 Mar 20.

PMID:
16545441
[PubMed - indexed for MEDLINE]
10.

Synchronous primary ovarian and endometrial cancers: a population-based assessment of survival.

Williams MG, Bandera EV, Demissie K, Rodríguez-Rodríguez L.

Obstet Gynecol. 2009 Apr;113(4):783-9. doi: 10.1097/AOG.0b013e31819c7bdf.

PMID:
19305320
[PubMed - indexed for MEDLINE]
11.

An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.

Gadducci A, Cosio S, Fanucchi A, Cristofani R, Genazzani AR.

Anticancer Res. 2000 May-Jun;20(3B):1977-84.

PMID:
10928137
[PubMed - indexed for MEDLINE]
12.

Is there a difference in outcome between stage I-II endometrial cancer of papillary serous/clear cell and endometrioid FIGO Grade 3 cancer?

Alektiar KM, McKee A, Lin O, Venkatraman E, Zelefsky MJ, McKee B, Hoskins WJ, Barakat RR.

Int J Radiat Oncol Biol Phys. 2002 Sep 1;54(1):79-85.

PMID:
12182977
[PubMed - indexed for MEDLINE]
13.

Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion.

Orezzoli JP, Sioletic S, Olawaiye A, Oliva E, del Carmen MG.

Gynecol Oncol. 2009 Jun;113(3):316-23. doi: 10.1016/j.ygyno.2009.03.007. Epub 2009 Apr 5.

PMID:
19345400
[PubMed - indexed for MEDLINE]
14.

Prognostic significance of DNA topoisomerase II-alpha (Ki-S1) immunoexpression in endometrial carcinoma.

Bildrici K, Tel N, Ozalp SS, Yalcin OT, Yilmaz V.

Eur J Gynaecol Oncol. 2002;23(6):540-4.

PMID:
12556100
[PubMed - indexed for MEDLINE]
15.

Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer.

Amant F, Cadron I, Fuso L, Berteloot P, de Jonge E, Jacomen G, Van Robaeys J, Neven P, Moerman P, Vergote I.

Gynecol Oncol. 2005 Aug;98(2):274-80.

PMID:
15972232
[PubMed - indexed for MEDLINE]
16.

Differences in treatment and outcome between African-American and white women with endometrial cancer.

Randall TC, Armstrong K.

J Clin Oncol. 2003 Nov 15;21(22):4200-6.

PMID:
14615448
[PubMed - indexed for MEDLINE]
17.

Are uterine risk factors more important than nodal status in predicting survival in endometrial cancer?

Kwon JS, Qiu F, Saskin R, Carey MS.

Obstet Gynecol. 2009 Oct;114(4):736-43. doi: 10.1097/AOG.0b013e3181b96ec6.

PMID:
19888029
[PubMed - indexed for MEDLINE]
18.

Endometrial carcinomas in women aged 40 years and younger: tumors associated with loss of DNA mismatch repair proteins comprise a distinct clinicopathologic subset.

Garg K, Shih K, Barakat R, Zhou Q, Iasonos A, Soslow RA.

Am J Surg Pathol. 2009 Dec;33(12):1869-77. doi: 10.1097/PAS.0b013e3181bc9866.

PMID:
19898223
[PubMed - indexed for MEDLINE]
19.

Epidemiologic and surgicopathologic findings of papillary serous and clear cell endometrial cancers when compared to endometrioid carcinoma.

Cirisano FD Jr, Robboy SJ, Dodge RK, Bentley RC, Krigman HR, Synan IS, Soper JT, Clarke-Pearson DL.

Gynecol Oncol. 1999 Sep;74(3):385-94.

PMID:
10479498
[PubMed - indexed for MEDLINE]
20.

A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer.

Secord AA, Havrilesky LJ, O'Malley DM, Bae-Jump V, Fleming ND, Broadwater G, Cohn DE, Gehrig PA.

Gynecol Oncol. 2009 Sep;114(3):442-7. doi: 10.1016/j.ygyno.2009.06.005. Epub 2009 Jun 26.

PMID:
19560193
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk